Aya Ishii-Shiba
Tsukuba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Clinicopathologic, Cellular, and Molecular Analyses of Pulmonary Neuroendocrine Carcinoma With High Expression of Hepatocyte Nuclear Factor 4 Alpha.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: November 28, 2024
Histologic transformation of non-small-cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms.
Journal: Cancer science
Published: February 26, 2024
Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: February 19, 2024
Expression patterns of HNF4α, TTF-1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features.
Journal: Virchows Archiv : an international journal of pathology
Published: January 30, 2024
Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report.
Journal: Pathology international
Published: February 22, 2022
Significance of stratifin in early progression of lung adenocarcinoma and its potential therapeutic relevance.
Journal: Pathology international
Published: May 18, 2021
Gene expression profiles of the original tumors influence the generation of PDX models of lung squamous cell carcinoma.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: June 25, 2020
DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma.
Journal: Oncotarget
Published: November 29, 2018
Stratifin Inhibits SCFFBW7 Formation and Blocks Ubiquitination of Oncoproteins during the Course of Lung Adenocarcinogenesis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 05, 2018
High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma.
Journal: Pathology international
Published: July 12, 2018
Last Updated: 09/26/2026